1. Home
  2. BCO vs ACAD Comparison

BCO vs ACAD Comparison

Compare BCO & ACAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCO
  • ACAD
  • Stock Information
  • Founded
  • BCO 1859
  • ACAD 1993
  • Country
  • BCO United States
  • ACAD United States
  • Employees
  • BCO N/A
  • ACAD N/A
  • Industry
  • BCO Oil Refining/Marketing
  • ACAD Biotechnology: Pharmaceutical Preparations
  • Sector
  • BCO Consumer Discretionary
  • ACAD Health Care
  • Exchange
  • BCO Nasdaq
  • ACAD Nasdaq
  • Market Cap
  • BCO 4.1B
  • ACAD 3.4B
  • IPO Year
  • BCO N/A
  • ACAD 2004
  • Fundamental
  • Price
  • BCO $91.68
  • ACAD $19.95
  • Analyst Decision
  • BCO Strong Buy
  • ACAD Buy
  • Analyst Count
  • BCO 3
  • ACAD 19
  • Target Price
  • BCO $120.50
  • ACAD $25.33
  • AVG Volume (30 Days)
  • BCO 220.0K
  • ACAD 1.7M
  • Earning Date
  • BCO 02-26-2025
  • ACAD 02-26-2025
  • Dividend Yield
  • BCO 1.06%
  • ACAD N/A
  • EPS Growth
  • BCO N/A
  • ACAD N/A
  • EPS
  • BCO 2.64
  • ACAD 0.78
  • Revenue
  • BCO $4,993,300,000.00
  • ACAD $929,236,000.00
  • Revenue This Year
  • BCO $3.70
  • ACAD $36.88
  • Revenue Next Year
  • BCO $2.61
  • ACAD $8.01
  • P/E Ratio
  • BCO $35.01
  • ACAD $25.70
  • Revenue Growth
  • BCO 3.60
  • ACAD 47.06
  • 52 Week Low
  • BCO $79.20
  • ACAD $14.15
  • 52 Week High
  • BCO $115.91
  • ACAD $26.56
  • Technical
  • Relative Strength Index (RSI)
  • BCO 44.68
  • ACAD 60.25
  • Support Level
  • BCO $91.14
  • ACAD $19.52
  • Resistance Level
  • BCO $94.89
  • ACAD $20.29
  • Average True Range (ATR)
  • BCO 1.96
  • ACAD 0.68
  • MACD
  • BCO -0.03
  • ACAD 0.08
  • Stochastic Oscillator
  • BCO 34.58
  • ACAD 72.62

About BCO Brinks Company (The)

The Brink's Co is a Global provider of secure logistics and security solutions for cash and other valuables. In 2020, the company acquired the U.K.-based G4S that reorganized its operating segments to be North America, Latin America, Europe, and Rest of World. It generates maximum revenue from the North America segment, namely from its core business of cash-in-transit and ATM services. The Latin America and Europe segments trail North America in revenue earnings with the Brinks Global Services line of business that specializes in the secure transportation of high-valued commodities, such as jewelry, precious metals, banknotes, and electronics. Brink's customer base includes financial institutions, retails, government agencies, mints, and other commercial businesses.

About ACAD ACADIA Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc is a biotechnology company that develops and commercializes biopharmaceutical products to address central nervous system disorders. The company aims to discover small molecules drugs that address disorders such as Parkinson's, Alzheimer's, and schizophrenia. Acadia also seeks to in-license or acquire complementary products and candidates. The company's patent applications claim proprietary technology, including novel methods of screening and chemical synthetic methods, novel drug targets, and novel compounds identified using its technology.

Share on Social Networks: